Due to limited stocks of the 87/586 non-WHO human recombinant IFNγ, a restriction of 3 ampoules per customer per year has been implemented. We would strongly encourage customers to plan accordingly and advise them to contact us with any other requirements and forecasted needs until a replacement preparation becomes available.